246 related articles for article (PubMed ID: 36527826)
1. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease.
Lv Y; Lou Y; Liu A; Cheng Q; Yang G; Xu C; Luo Y; Lou J; Yu J; Fang Y; Zhao H; Peng K; Ni Y; Chen J
Clin Nutr; 2023 Feb; 42(2):116-128. PubMed ID: 36527826
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
Svolos V; Hansen R; Nichols B; Quince C; Ijaz UZ; Papadopoulou RT; Edwards CA; Watson D; Alghamdi A; Brejnrod A; Ansalone C; Duncan H; Gervais L; Tayler R; Salmond J; Bolognini D; Klopfleisch R; Gaya DR; Milling S; Russell RK; Gerasimidis K
Gastroenterology; 2019 Apr; 156(5):1354-1367.e6. PubMed ID: 30550821
[TBL] [Abstract][Full Text] [Related]
3. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease.
Jones CMA; Connors J; Dunn KA; Bielawski JP; Comeau AM; Langille MGI; Van Limbergen J
Inflamm Bowel Dis; 2020 Jun; 26(7):1026-1037. PubMed ID: 31961432
[TBL] [Abstract][Full Text] [Related]
4. Reverse-engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial.
Lee D; Braly K; Nuding M; Braly I; Hopp C; Twible H; Pope C; Hayden HS; Hoffman L; Zheng H; Wahbeh G; Suskind DL
J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1135-1142. PubMed ID: 38558411
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
Zhou S; Huang Z; Hou W; Lin Y; Yu J
Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review.
MacLellan A; Moore-Connors J; Grant S; Cahill L; Langille MGI; Van Limbergen J
Nutrients; 2017 May; 9(5):. PubMed ID: 28468301
[TBL] [Abstract][Full Text] [Related]
7. Exclusive Enteral Nutrition Beneficially Modulates Gut Microbiome in a Preclinical Model of Crohn's-like Colitis.
Geesala R; Recharla N; Zhang K; Johnson JC; Golovko G; Khanipov K; Brining DL; Shi XZ
Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337648
[TBL] [Abstract][Full Text] [Related]
8. Exclusive Enteral Nutrition Exerts Anti-Inflammatory Effects through Modulating Microbiota, Bile Acid Metabolism, and Immune Activities.
Xiao F; Gao X; Hu H; Le J; Chen Y; Shu X; Liang Z; Xu Y; Wang Y; Zhang T
Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364726
[TBL] [Abstract][Full Text] [Related]
9. Extensive Modulation of the Fecal Metagenome in Children With Crohn's Disease During Exclusive Enteral Nutrition.
Quince C; Ijaz UZ; Loman N; Eren AM; Saulnier D; Russell J; Haig SJ; Calus ST; Quick J; Barclay A; Bertz M; Blaut M; Hansen R; McGrogan P; Russell RK; Edwards CA; Gerasimidis K
Am J Gastroenterol; 2015 Dec; 110(12):1718-29; quiz 1730. PubMed ID: 26526081
[TBL] [Abstract][Full Text] [Related]
10. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition.
Gerasimidis K; Bertz M; Hanske L; Junick J; Biskou O; Aguilera M; Garrick V; Russell RK; Blaut M; McGrogan P; Edwards CA
Inflamm Bowel Dis; 2014 May; 20(5):861-71. PubMed ID: 24651582
[TBL] [Abstract][Full Text] [Related]
11. Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease.
Diederen K; Li JV; Donachie GE; de Meij TG; de Waart DR; Hakvoort TBM; Kindermann A; Wagner J; Auyeung V; Te Velde AA; Heinsbroek SEM; Benninga MA; Kinross J; Walker AW; de Jonge WJ; Seppen J
Sci Rep; 2020 Nov; 10(1):18879. PubMed ID: 33144591
[TBL] [Abstract][Full Text] [Related]
12. Exclusive enteral nutrition remodels the intestinal flora in patients with active Crohn's disease.
Jiang J; Chen L; Chen Y; Chen H
BMC Gastroenterol; 2022 Apr; 22(1):212. PubMed ID: 35501724
[TBL] [Abstract][Full Text] [Related]
13. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
[TBL] [Abstract][Full Text] [Related]
14. Effect of Exclusive Enteral Nutrition on the Disease Process, Nutrition Status, and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease.
Tang W; Huang Y; Shi P; Wang Y; Zhang Y; Xue A; Tang Z; Hu W; Sun H; Zhang P; Zheng C; Shi J; Wang S; Qiu X; Lu X; Miao S; Meng Y
JPEN J Parenter Enteral Nutr; 2021 May; 45(4):826-838. PubMed ID: 32510616
[TBL] [Abstract][Full Text] [Related]
15. Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn's disease.
Nichols B; Briola A; Logan M; Havlik J; Mascellani A; Gkikas K; Milling S; Ijaz UZ; Quince C; Svolos V; Russell RK; Hansen R; Gerasimidis K
Am J Clin Nutr; 2024 Apr; 119(4):885-895. PubMed ID: 38569785
[TBL] [Abstract][Full Text] [Related]
16. Enteral Nutrition in the Management of Pediatric and Adult Crohn's Disease.
Hansen T; Duerksen DR
Nutrients; 2018 Apr; 10(5):. PubMed ID: 29701656
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease.
Copova I; Hradsky O; Zarubova K; Gonsorcikova L; Potuznikova K; Lerchova T; Nevoral J; Bronsky J
Eur J Pediatr; 2018 Nov; 177(11):1685-1693. PubMed ID: 30128744
[TBL] [Abstract][Full Text] [Related]
18. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
Zubin G; Peter L
Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
[TBL] [Abstract][Full Text] [Related]
19. Exclusive Enteral Nutrition Induces Remission in Pediatric Crohn's Disease via Modulation of the Gut Microbiota.
Gong D; Yu X; Wang L; Kong L; Gong X; Dong Q
Biomed Res Int; 2017; 2017():8102589. PubMed ID: 29124070
[TBL] [Abstract][Full Text] [Related]
20. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
